Vaccination strategies in children infected with human immunodeficiency virus (HIV) a r e controversial; live virus vaccines a r e generally contraindicated in immunodeficient children. 23 HIV-infected children received a t least 2 doses (median = 3) of oral polio vaccine (oPV) before HIV infection was suspected, 3 others received inactivated polio vaccine (IPV). The median interval from OPV immunization t o serum sampling was 2.8 years (range 1 mo to 15 yrs), the median interval from IPV immunization to sampling was 1 mo (range 1 t o 4 mo). Congenital HIV infection was present in 23 and postnatally acquired infection was present in 3. Antibody t o poliovirus 2 was determined by microneutralization. Protective levels of antibody 1:4) were found in 21/23 (91%) of persons given OPV (GMT = 22.9), and in 313 given IPV (GMT = 25.4). The stage of clinical illness correlated with the antibody titer; patients with AIDS had a GMT = 5.7, patients with ARC had a GMT = 26.9, and HIV infected apparently well children had a GMT = 84.4.
= 26.9, and HIV infected apparently well children had a GMT = 84.4.
Protective levels of antibody occur in t h e majority of HIV infected children immunized against poliovirus type 2. The potential for rare adverse events and intrafamilial spread suggests t h a t IPV is t h e preferred vaccine for HIV infected children. Although no adverse events, attributable t o polio vaccination, were documented in these children, further study of t h e effects of vaccination on t h e manifestations of HIV infection is needed. 
HETEROGENEITY OF NEUTROPHIL (PMN) FUNCTION AND MONO-CLONAL ANTIBODY (MAb) BINDING I N NEONATES AND ADULTS

of P e d i a t r i c s , H a r t f o r d , CT S t u d i e s have shown t h a t PMN from a d u l t s and neonates e x h i b i t h e t e r o g e n e i t y of f u n c t i o n and 31D8 MAb binding.
The h e t e r o g e n i t y of 31D8 binding c o r r e l a t e s with PMN m o t i l e h e t e r o g e n e i t y . M01 MAb binds t o PMN g l y c o p r o t e i n s which allow t h e PMN t o adher= and move normally. We f u r t h e r s t u d i e d PMN h e t e r o g e n e i t y i n 10 neo n a t e s and 10 a d u l t s by placing PMN i n t h e upper compartment of chemotactic chambers and allowing them t o t r a n s v e r s e 10 um polycarbonate f i l t e r s i n response t o C5 f r a g . PMN were analyzed f o r v i a b i l i t y , band count and MAb binding with 31D8 acd MO! .
The % of non-motile (NM) n e o n a t a l and a d u l t PMN recovered from t h e upper compartment a f t e r 90 min. were 7 + 1% and 4 + I.%, r e s p e c t i v e l y (P<0.01).
The % highly m o t i l e (HM) neonatal and a d u l t PMN from t h e lower compartment were 5 + 2% and 11 2 2 X , r e s p e c t i v e l y (P<0.01). The v i a b i l i t y and % bands i n NM PMN were not s i g n i f i c a n t l y d i f f e r e n t from c o n t r o l PMN. The NM PMN had s i g n i f i c a n t l y l e s s 31D8 and M01 MAb binding t h a n t h e HM PMN subpopulations. Neonatal NM and HM PMN had s i g n i f i c a n t l y l e s s 31D8 and M01 MAb binding t h a n a d u l t NM and HM PMN. These d a t a suggest t h a t v a r i a b l e 31D8 and M01 a n t i g e n expression may c o n t r i b u t e t o d i f f e r e n c e s i n m o t i l e subpopulations of PMN i n neonates and a d u l t s and a r e a t l e a s t i n p a r t r e s p o n s HIV i n f e c t i o n i n i n f a n t s i s u s u a l l y documented by t h e presence of serum Ab t o t h e v i r u s . I n d i v i d u a l s who a r e p e r s i s t e n t l y v i r emic b u t without d e t e c t a b l e serum Ab have been reported. A 4 molth o l d i n f a n t of a p a r e n t e r a l drug abuser presented w i t h f a i l u r e t o t h r i v e , generalized lymphadenopathy and hepatosplenomegaly; a t 6 mos of age Pneumocystis c a r i n i i pneumonitis developed.
I n i t i a l e v a l u a t i o n (age 4 mos) revealed polyclonal hypergammaglobulinemia, T4/Tg = 1.5 and a b s o l u t e lymphocyte count = 6460Imm3. R e s u l t s of l o n g i t u d i n a l s e r o l o g i c a l e v a l u a t i o n s a r e sunmiarized i n t h e t a b l e . 
i -t b
This prolonged h i g h grade nntigenemia i n t h e presence of low leve l s of s p e c i f i c Ab is analogous t o t h e phenomenon of pseudot o l e r a n c e observed i n c o n g e n i t a l r u b e l l a and cytomegalovirus inf e c t i o n s and suggests t h a t t h i s i n f a n t was i n f e c t e d i n utero. I n i n f a n t s a t r i s k f o r HIV i n f e c t i o n Ab a s s a y s a l o n e may prove t o b e inadequate f o r diagnosis. V i r a l i s o l a t i o n and/or HIV Ag detect i o n techniques a r e important t o o l s i n such s i t u a t i o n s . RSV b r o n c h i o l i t i s occurs i n i n f a n t s <6pos of age i n t h e presence of maternally acquired antibody (Ab).
A killed-RSV vaccine a l s o produced serum Ab responses b u t r e c i p i e n t s developed s e v e r e d i s e a s e w i t h subsequent n a t u r a l RSV i n f e c t i o n .
To determine i f anti-RSV Ab might c o n t r i b u t e t o t h e d i s e a s e ' s pathogenesis, P388D1 c e l l s were i n f e c t e d i n v i t r o w i t h RSV a t a MOI of 0.025 i n t h e presence of s e r i a l 4-fold d i l u t i o n s of monoclonal (mc) Ab t o t h e f u s i o n (F), g l y c o p r o t e i n (G), o r nucleocapsid (NC) p r o t e i n s of RSV. C e l l s were washed a f t e r 2hr of v i r a l a d s o r p t i o n and every 24h f o r 48h. At 48h c e l l s were s t a i n e d w i t h a f l u o r e s c e n t Ab t o RSV and t h e p e r c e n t of RSV-positive c e l l s was determined u s i n g a FACS-analyzer w i t h Consort 30 software. Supernatants were t e s t e d f o r i n f e c t i o u s v i r u s production by plaque assay on HEp-2 monol a y e r s . Data were analyzed by comparing Ab-treated c e l l s w i t h c e l l s i n f e c t e d w i t h no anti-RSV Ab p r e s e n t . AME was demonstrated a t d i l u t i o n s of 1:800 t o 1:25,600 f o r anti-F and anti-G Ab t r e a t e d c e l l s by FACS a n a l y s i s .
(Anti-F:8.3-9.8% (+) v s 3.1% (+) i n RSVonly, ~( 0 . 0 1 ; anti-G:26.0-40.6~ (+) v s 11.8% (+) i n RSV-only, ~( 0 . 0 1 . ) Maximal i n f e c t i o u s v i r u s production a t 48h was increased by 2 1 log. (Anti-F a t 1 : 6 4 0 0 = 2 . 4~1 0~ PFU/ml v s 1 . 3~1 0 3 f o r RSV only; anti-G a t 1:400=2.2~103 PmT/ml v s 2 . 1~1 0 2 f o r RSV only3 C e l l s t r e a t e d w i t h anti-NC Ab o r an i r r e l e v a n t mc Ab a t t h e same d i l u t i o n s showed no s i g n i f i c a n t AME. This model s u g g e s t s a p o s s i b l e r o l e f o r AME i n t h e pathogenesis o f i n vivo d i s e a s e .
KINETICS OF HAEMOPHILUS INFLUENZAE TYPE B ANTIGENURIA FOLLOWING IMMUNIZATION AND NATURAL INFECTION. L.J.
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The k i n e t i c s of Haemophilus i n f l u e n z a e type b (Hib) a n t i g e n u r
i a was determined i n c h i l d r e n r e c e i v i n g Hib vaccine and o t h e r s u b j e c t s h o s p i t a l i z e d f o r n a t u r a l i n f e c t i o n with Hib who presented with m e n i n g i t i s , e p i g l o t t i t i s , s e p t i c a r t h r i t i s and pneumonia.
Urine specimens were c o l l e c t e d b e f o r e immunization and on days (d) 1, 3 , 7 and 10 post-vaccination, o r p r i o r t o a n t i b i o t i c therapy and a t r e g u l a r i n t e r v a l s during h o s p i t a l i z a t i o n . Q u a n t i t a t i o n of t h e PRP a n t i g e n was achieved by t h e use of a n i n d i r e c t ELISA method. A l l vaccine r e c i p i e n t s were negative f o r PRP p r i o r t o immunization. The peak concentrat i o n of PRP e x c r e t i o n occured on t h e f i r s t day a f t e r immunizat i o n a t 87% and declined t o 73% by d 3 and 13% by d 10. Children excreted t h e h i g h e s t c o n c e n t r a t i o n of a n t i g e n on d 1 and 3 a f t e r immunization (129 and 131 ng/ml) which declined t o 0.92 ng/ml on d 7. Children with n a t u r a l i n f e c t i o n had a peak e x c r e t i o n on t h e f i r s t 3 days of h o s p i t a l i z a t i o n a t 88% which declined t o 60% by d 7 and 33% by d 9. Children w i t h n a t u r a l i n f e c t i o n excreted higher c o n c e n t r a t i o n s of PRP a n t i g e n , f i r s t 3 days mean 286 ngfml, than vaccine r e c i p i e n t s , and e x c r e t i o n declined t o 102 ngfinl by d 7 and 15 ng/ml by d 9. The magnitude of PRP e x c r e t i o n was a d i r e c t f u n c t i o n of t h e type of Hib i n f e c t i o n . Furthermore, immunization with Hib vaccine can be a s s o c i a t e d with a n t i g e n u r i a , and a p o s i t i v e d i a g n o s t i c a n t i g e n t e s t may not i n d i c a t e i n f e c t i o n i n t h e r e c e n t l y vaccinated c h i l d .
RESPONSE T O VARICELLA ZOSTER VIRUS (VZV)
GLYCOPROTEWS ( Three major VZV GPs [l, 2,3] have been identified. W e used a Dot-ELISA to determine the geometric mean titer [GMTI of antibody to these GPs in children with ALL who had past natural varicella (NV) or who received the live attenuated varicella vaccine(LAVV). In vaccinees with household exposure(HHE) to VZV (n=24), pre-HHE (n=19,%=13 months post-LAVV) GMTs to all GPs were low in sera from those who subsequently developed lesions (n = 7)[GMTs = 33,38, 181 and in those who did not (n = 12)[GMTs = 74, 12, 61. Post-HHE GMTs were higher in those who developed lesions (n = 7)[GMTs = 1413, 1050,7801 compared to those who did not (n = 17) [GMTs = 127, 71, 47] . Vaccinees who developed zoster(Z) (n = 5,R = 15 months post-LAVV) had lower pre-Z GMTs [127, 21, 81 than vaccinees who did not (n=30,X=12 months post-LAVV) [GMTs =197, 62, 40] . Post-Z GMTs showed boosts for all GPs [GMTs=1940, 1689 . Unvaccinated children with ALL & NV who developed Z (n = 1 2 ,~ = 20 months post-NV) had the following GMTs [269,51, 101 compared to those who did not (n = 303 = 42 months after NV) [GMTs = 182, 112, 201 . Post-Z GMTs showed boosts for all GPs (n=6) LGMTs = 640,640,5701. In summary, GMTs to GP-1 > 2 > 3. In vaccinees, at the time of HHE, the height of the antibody titer to the GPs was not helpful in predicting protection from development of breakthrough lesions, but a boost was most evident in those who did develop lesions, probably due to greater viral replication in vesicles. Vaccinees who developed Z had lower GMTs to all GPs, but especially to GP-3, compared to those who did not. Unvaccinated children with ALL & NV who developed Z had lower GMTs to both GP-2 & 3 compared to those who did not.
